Selected research
Market Analysis & Forecast
Global Glucoraphanin Market Analysis and Forecast 2026-2032
Market perspective
The global Glucoraphanin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Glucoraphanin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Glucoraphanin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Glucoraphanin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Glucoraphanin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Glucoraphanin include CS Health, Brassica Protection Product（BPP）, Pioneer Herb Industrial, Nutramax Laboratories, Shenzhen Fushan Biotechnology, Chengdu SanHerb BioScience, Xi`an App-Chem Bio (Tech), Wellgreen Technology and Anhui Bensentang Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Glucoraphanin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Glucoraphanin, also provides the sales of main regions and countries. Of the upcoming market potential for Glucoraphanin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucoraphanin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glucoraphanin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glucoraphanin sales, projected growth trends, production technology, application and end-user industry.
Glucoraphanin Segment by Company
CS Health
Brassica Protection Product（BPP）
Pioneer Herb Industrial
Nutramax Laboratories
Shenzhen Fushan Biotechnology
Chengdu SanHerb BioScience
Xi`an App-Chem Bio (Tech)
Wellgreen Technology
Anhui Bensentang Biotechnology
Glucoraphanin Segment by Type
<10% Glucoraphanin
10-15% Glucoraphanin
>15% Glucoraphanin
Glucoraphanin Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Glucoraphanin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucoraphanin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucoraphanin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucoraphanin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Glucoraphanin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Glucoraphanin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucoraphanin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- <10% Glucoraphanin
- 10-15% Glucoraphanin
- >15% Glucoraphanin
Applications
- Health Products
- Functional Foods
- Pharmaceutical
- Others
Companies covered
- CS Health
- Brassica Protection Product（BPP）
- Pioneer Herb Industrial
- Nutramax Laboratories
- Shenzhen Fushan Biotechnology
- Chengdu SanHerb BioScience
- Xi`an App-Chem Bio (Tech)
- Wellgreen Technology
- Anhui Bensentang Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Glucoraphanin Market by Type
- 1.2.1 Global Glucoraphanin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 <10% Glucoraphanin
- 1.2.3 10-15% Glucoraphanin
- 1.2.4 >15% Glucoraphanin
- 1.3 Glucoraphanin Market by Application
- 1.3.1 Global Glucoraphanin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Health Products
- 1.3.3 Functional Foods
- 1.3.4 Pharmaceutical
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Glucoraphanin Market Dynamics
- 2.1 Glucoraphanin Industry Trends
- 2.2 Glucoraphanin Industry Drivers
- 2.3 Glucoraphanin Industry Opportunities and Challenges
- 2.4 Glucoraphanin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Glucoraphanin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Glucoraphanin Revenue by Region
- 3.2.1 Global Glucoraphanin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Glucoraphanin Revenue by Region (2021-2026)
- 3.2.3 Global Glucoraphanin Revenue by Region (2027-2032)
- 3.2.4 Global Glucoraphanin Revenue Market Share by Region (2021-2032)
- 3.3 Global Glucoraphanin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Glucoraphanin Sales by Region
- 3.4.1 Global Glucoraphanin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Glucoraphanin Sales by Region (2021-2026)
- 3.4.3 Global Glucoraphanin Sales by Region (2027-2032)
- 3.4.4 Global Glucoraphanin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Glucoraphanin Revenue by Manufacturers
- 4.1.1 Global Glucoraphanin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Glucoraphanin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Glucoraphanin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Glucoraphanin Sales by Manufacturers
- 4.2.1 Global Glucoraphanin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Glucoraphanin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Glucoraphanin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Glucoraphanin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Glucoraphanin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Glucoraphanin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Glucoraphanin Manufacturers, Product Type & Application
- 4.7 Global Glucoraphanin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Glucoraphanin Market CR5 and HHI
- 4.8.2 2025 Glucoraphanin Tier 1, Tier 2, and Tier 3
5 Glucoraphanin Market by Type
- 5.1 Global Glucoraphanin Revenue by Type
- 5.1.1 Global Glucoraphanin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Glucoraphanin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Glucoraphanin Revenue Market Share by Type (2021-2032)
- 5.2 Global Glucoraphanin Sales by Type
- 5.2.1 Global Glucoraphanin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Glucoraphanin Sales by Type (2021-2032) & (t)
- 5.2.3 Global Glucoraphanin Sales Market Share by Type (2021-2032)
- 5.3 Global Glucoraphanin Price by Type
6 Glucoraphanin Market by Application
- 6.1 Global Glucoraphanin Revenue by Application
- 6.1.1 Global Glucoraphanin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Glucoraphanin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Glucoraphanin Revenue Market Share by Application (2021-2032)
- 6.2 Global Glucoraphanin Sales by Application
- 6.2.1 Global Glucoraphanin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Glucoraphanin Sales by Application (2021-2032) & (t)
- 6.2.3 Global Glucoraphanin Sales Market Share by Application (2021-2032)
- 6.3 Global Glucoraphanin Price by Application
7 Company Profiles
- 7.1 CS Health
- 7.1.1 CS Health Company Information
- 7.1.2 CS Health Business Overview
- 7.1.3 CS Health Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 CS Health Glucoraphanin Product Portfolio
- 7.1.5 CS Health Recent Developments
- 7.2 Brassica Protection Product（BPP）
- 7.2.1 Brassica Protection Product（BPP） Company Information
- 7.2.2 Brassica Protection Product（BPP） Business Overview
- 7.2.3 Brassica Protection Product（BPP） Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Brassica Protection Product（BPP） Glucoraphanin Product Portfolio
- 7.2.5 Brassica Protection Product（BPP） Recent Developments
- 7.3 Pioneer Herb Industrial
- 7.3.1 Pioneer Herb Industrial Company Information
- 7.3.2 Pioneer Herb Industrial Business Overview
- 7.3.3 Pioneer Herb Industrial Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pioneer Herb Industrial Glucoraphanin Product Portfolio
- 7.3.5 Pioneer Herb Industrial Recent Developments
- 7.4 Nutramax Laboratories
- 7.4.1 Nutramax Laboratories Company Information
- 7.4.2 Nutramax Laboratories Business Overview
- 7.4.3 Nutramax Laboratories Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Nutramax Laboratories Glucoraphanin Product Portfolio
- 7.4.5 Nutramax Laboratories Recent Developments
- 7.5 Shenzhen Fushan Biotechnology
- 7.5.1 Shenzhen Fushan Biotechnology Company Information
- 7.5.2 Shenzhen Fushan Biotechnology Business Overview
- 7.5.3 Shenzhen Fushan Biotechnology Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Shenzhen Fushan Biotechnology Glucoraphanin Product Portfolio
- 7.5.5 Shenzhen Fushan Biotechnology Recent Developments
- 7.6 Chengdu SanHerb BioScience
- 7.6.1 Chengdu SanHerb BioScience Company Information
- 7.6.2 Chengdu SanHerb BioScience Business Overview
- 7.6.3 Chengdu SanHerb BioScience Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Chengdu SanHerb BioScience Glucoraphanin Product Portfolio
- 7.6.5 Chengdu SanHerb BioScience Recent Developments
- 7.7 Xi`an App-Chem Bio (Tech)
- 7.7.1 Xi`an App-Chem Bio (Tech) Company Information
- 7.7.2 Xi`an App-Chem Bio (Tech) Business Overview
- 7.7.3 Xi`an App-Chem Bio (Tech) Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Xi`an App-Chem Bio (Tech) Glucoraphanin Product Portfolio
- 7.7.5 Xi`an App-Chem Bio (Tech) Recent Developments
- 7.8 Wellgreen Technology
- 7.8.1 Wellgreen Technology Company Information
- 7.8.2 Wellgreen Technology Business Overview
- 7.8.3 Wellgreen Technology Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Wellgreen Technology Glucoraphanin Product Portfolio
- 7.8.5 Wellgreen Technology Recent Developments
- 7.9 Anhui Bensentang Biotechnology
- 7.9.1 Anhui Bensentang Biotechnology Company Information
- 7.9.2 Anhui Bensentang Biotechnology Business Overview
- 7.9.3 Anhui Bensentang Biotechnology Glucoraphanin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Anhui Bensentang Biotechnology Glucoraphanin Product Portfolio
- 7.9.5 Anhui Bensentang Biotechnology Recent Developments
8 North America
- 8.1 North America Glucoraphanin Market Size by Type
- 8.1.1 North America Glucoraphanin Revenue by Type (2021-2032)
- 8.1.2 North America Glucoraphanin Sales by Type (2021-2032)
- 8.1.3 North America Glucoraphanin Price by Type (2021-2032)
- 8.2 North America Glucoraphanin Market Size by Application
- 8.2.1 North America Glucoraphanin Revenue by Application (2021-2032)
- 8.2.2 North America Glucoraphanin Sales by Application (2021-2032)
- 8.2.3 North America Glucoraphanin Price by Application (2021-2032)
- 8.3 North America Glucoraphanin Market Size by Country
- 8.3.1 North America Glucoraphanin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Glucoraphanin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Glucoraphanin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Glucoraphanin Market Size by Type
- 9.1.1 Europe Glucoraphanin Revenue by Type (2021-2032)
- 9.1.2 Europe Glucoraphanin Sales by Type (2021-2032)
- 9.1.3 Europe Glucoraphanin Price by Type (2021-2032)
- 9.2 Europe Glucoraphanin Market Size by Application
- 9.2.1 Europe Glucoraphanin Revenue by Application (2021-2032)
- 9.2.2 Europe Glucoraphanin Sales by Application (2021-2032)
- 9.2.3 Europe Glucoraphanin Price by Application (2021-2032)
- 9.3 Europe Glucoraphanin Market Size by Country
- 9.3.1 Europe Glucoraphanin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Glucoraphanin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Glucoraphanin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Glucoraphanin Market Size by Type
- 10.1.1 China Glucoraphanin Revenue by Type (2021-2032)
- 10.1.2 China Glucoraphanin Sales by Type (2021-2032)
- 10.1.3 China Glucoraphanin Price by Type (2021-2032)
- 10.2 China Glucoraphanin Market Size by Application
- 10.2.1 China Glucoraphanin Revenue by Application (2021-2032)
- 10.2.2 China Glucoraphanin Sales by Application (2021-2032)
- 10.2.3 China Glucoraphanin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Glucoraphanin Market Size by Type
- 11.1.1 Asia Glucoraphanin Revenue by Type (2021-2032)
- 11.1.2 Asia Glucoraphanin Sales by Type (2021-2032)
- 11.1.3 Asia Glucoraphanin Price by Type (2021-2032)
- 11.2 Asia Glucoraphanin Market Size by Application
- 11.2.1 Asia Glucoraphanin Revenue by Application (2021-2032)
- 11.2.2 Asia Glucoraphanin Sales by Application (2021-2032)
- 11.2.3 Asia Glucoraphanin Price by Application (2021-2032)
- 11.3 Asia Glucoraphanin Market Size by Country
- 11.3.1 Asia Glucoraphanin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Glucoraphanin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Glucoraphanin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Glucoraphanin Market Size by Type
- 12.1.1 SAMEA Glucoraphanin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Glucoraphanin Sales by Type (2021-2032)
- 12.1.3 SAMEA Glucoraphanin Price by Type (2021-2032)
- 12.2 SAMEA Glucoraphanin Market Size by Application
- 12.2.1 SAMEA Glucoraphanin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Glucoraphanin Sales by Application (2021-2032)
- 12.2.3 SAMEA Glucoraphanin Price by Application (2021-2032)
- 12.3 SAMEA Glucoraphanin Market Size by Country
- 12.3.1 SAMEA Glucoraphanin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Glucoraphanin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Glucoraphanin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Glucoraphanin Value Chain Analysis
- 13.1.1 Glucoraphanin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Glucoraphanin Production Mode & Process
- 13.2 Glucoraphanin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Glucoraphanin Distributors
- 13.2.3 Glucoraphanin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst